Medical Doctor Program year 2025 Reported 2019–2025 Source: CMS Open Payments, 2026 publication

Marcelo Jimenez

Clinical Cardiac Electrophysiology Atlantis, FL Medical Doctor

NPI 1336332717 CMS profile 1198457

180 Jfk Dr, Suite 311, Atlantis, FL 33462

Open in the dashboard

General payments

$294,896

962 records reported · program years 2019–2025

Research payments

$475

Paid to them · 1 record reported · program years 2019–2025

Ownership & investment interest

$124,846

3 holdings reported · through program year 2025

Through program year 2025, Marcelo Jimenez of Atlantis, FL is reported in the CMS Open Payments database as having received $294,896 across 962 general payments and $475 in research payments paid to them. They also declared ownership or investment interests valued at $124,846 across 3 holdings.

No combined total General, research and ownership are kept apart. Each is reported under its own rules, and ownership is not money that moved at all but the value of a stake held. A meal, a clinical trial grant and a shareholding do not add up to anything meaningful, so this site does not add them.

General payments for this record sit in the 96th percentile of Clinical Cardiac Electrophysiology profiles with reported payments. Percentile describes the distribution, not the conduct.

By program year

11 rows
Year Kind Relative to this record's peak year Amount Records
2025 General $90,119 154
2024 General $84,807 239
2023 General $47,217 218
2022 General $58,502 153
2022 Research $475 1
2021 General $4,590 34
2020 General $6,732 53
2019 General $2,930 111
2025 Ownership $44,588 1
2024 Ownership $44,588 1
2023 Ownership $35,670 1

Beside peers

Year by year, beside peers General payments · among profiles paid that year
  • Marcelo Jimenez
  • Clinical Cardiac Electrophysiology median
  • Middle half of Clinical Cardiac Electrophysiology
  • National median

In program year 2025, general payments to Marcelo Jimenez were reported at $90,119. Among 3,064 Clinical Cardiac Electrophysiology profiles paid that year, the median was $2,462 and the middle half received between $733 and $7,710.

Show as a table
Year Marcelo Jimenez Clinical Cardiac Electrophysiology median Middle half National median
2019 $2,930 $2,361 $585–$8,260 $163
2020 $6,732 $993 $247–$4,351 $114
2021 $4,590 $1,185 $326–$4,739 $132
2022 $58,502 $2,073 $554–$6,789 $149
2023 $47,217 $2,568 $759–$8,159 $160
2024 $84,807 $2,557 $703–$7,403 $164
2025 $90,119 $2,462 $733–$7,710 $169

Breakdown

Who paid General payments · program years 2019–2025
  1. Biosense Webster, Inc. $128,546 306 payments
  2. Medical Device Business Services, Inc. $121,309 61 payments
  3. Medtronic, Inc. $19,034 203 payments
  4. Abbott Laboratories $11,481 189 payments
  5. ZOLL Services LLC (A/K/A ZOLL LifeCor Corp) $5,186 31 payments
  6. Medtronic Vascular, Inc. $4,952 97 payments
  7. Boston Scientific Corporation $1,058 11 payments
  8. Cardiva Medical, Inc. $800 19 payments
  9. Philips Electronics North America Corporation $426 5 payments
  10. Sanofi-Aventis U.S. LLC $359 7 payments
  11. Other $1,744 33 payments

Every payment, record by record

What the payments were for General payments · program years 2019–2025
  1. Consulting Fee $223,209 73 payments
  2. Food and Beverage $31,776 810 payments
  3. Travel and Lodging $28,181 66 payments
  4. Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program $11,700 12 payments
  5. Education $30 1 payment
Products named General payments · program years 2019–2025
  1. Carto 3 $239,423 232 payments
  2. LifeVest $5,186 31 payments
  3. Reveal LINQ $3,167 17 payments
  4. Micra $2,282 33 payments
  5. Carto 3 System $2,254 14 payments
  6. AZURE XT DR MRI SURESCAN $2,119 49 payments
  7. AMPLATZER AMULET $2,054 23 payments
  8. ENSITE $1,710 10 payments
  9. AVEIR $1,683 45 payments
  10. ENSITE PRECISION $1,665 20 payments
  11. Other $21,551 461 payments

A payment can name more than one product, so these amounts overlap and do not add up to the general-payment figure.

Research payments came from Research payments · program years 2019–2025
  1. Medtronic, Inc. $475 1 payment

Prescribing to Medicare patients

Part D · data year 2024 · 8 drugs

Part D claims

438

Median for Clinical Cardiac Electrophysiology: 1,090

Drug cost

$186,565

Median for Clinical Cardiac Electrophysiology: $354,841

Branded share of claims

60.3%

Median for Clinical Cardiac Electrophysiology: 38.3%

Drugs this doctor was counted under in Medicare Part D 2024, by drug cost
Drug Type Relative to their largest Claims Drug cost
Eliquis Apixaban Brand 198 $149,403
Xarelto Rivaroxaban Brand 17 $17,513
Multaq Dronedarone Hcl Brand 16 $15,805
Flecainide Acetate Generic 55 $2,091
Metoprolol Succinate Generic 62 $695
Amiodarone Hcl Generic 41 $636
Clopidogrel Clopidogrel Bisulfate Brand 33 $351
Carvedilol Generic 16 $71

Drug cost is what was paid for the drugs at the pharmacy — by Medicare, the patient and others — and is not money to the prescriber. Medicare Part D only: drugs dispensed to Medicare beneficiaries. A drug with fewer than 11 claims for this prescriber is not published, so a missing drug does not mean zero. The medians are for the 2,573 Part D prescribers listed as Clinical Cardiac Electrophysiology; they describe a distribution and say nothing about conduct.

Billing to Medicare

Part B · data year 2024 · 68 billing codes

Paid by Medicare

$708,789

Medicare's payments for the services billed

Medicare patients

918

Average age 78

Services billed

5,393

362 women, 556 men among their patients

Share of this provider's Medicare patients with each condition
Condition among their Medicare patients Relative to the most common Share of patients
High blood pressure 75%
Atrial fibrillation 75%
Ischemic heart disease 63%
Heart failure 52%
Arthritis 50%
Chronic kidney disease 41%
Diabetes 40%
Depression 23%

Medicare Part B only: services billed to Medicare. Rows covering fewer than 11 beneficiaries are not published. Only drugs given in the clinic are itemised here; the rest of what this provider billed is in the total above.

Payments and prescribing

1 product · payments 2024

Two separate records. The payments come from Open Payments and the claims from Medicare. They are set side by side because they name the same product; they do not show that a payment affected a prescription.

Products this doctor was paid in connection with in 2024, beside Medicare claims for the same product
Product Paid by Related payments Part D claims Part B services
ELIQUIS
$21 198 —

A dash means Medicare published no figure for this doctor and product — fewer than 11 claims, or the product is not covered under that part — which is not the same as none. Payments are general payments only; one that names several products is split evenly between them, so an amount is payments related to the product, not money paid for it.

Records

963 reported

Every payment, record by record

Date, company, amount, what it was for and the product named — filter by year, kind and company, or download as CSV.

Other Clinical Cardiac Electrophysiology in Florida

Related records

What this means

U.S. law requires drug and medical device manufacturers to report payments and transfers of value they make to physicians and teaching hospitals. The Centers for Medicare & Medicaid Services publishes that record each year. This page shows what was reported about this person, and nothing else.

An ownership interest is different from the other two. It is not a payment: it is a stake — shares, options, a partnership holding — that a physician or an immediate family member held in a manufacturer during that year. The figure shown is what the stake was reported to be worth.

Research payments frequently pass through a clinician to the institution running a trial, and rarely represent personal income. They should be read differently from general payments.

Provenance

Source: CMS Open Payments · through program year 2025

Data current to program year 2025, from CMS's 2026 publication.

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record